Helen M. Rice

UCL Queen Square Institute Of Neurology
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.

Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.

Journal: medRxiv : the preprint server for health sciences
Published: April 10, 2026

Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.

Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: March 30, 2026

Accelerated long-term forgetting as a predictor of clinical onset in presymptomatic autosomal dominant Alzheimer's disease.

Accelerated long-term forgetting as a predictor of clinical onset in presymptomatic autosomal dominant Alzheimer's disease.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: May 20, 2025

Effects of attenuated influenza virus administration to young children on pneumococcal density and acquisition in UK families: a randomised controlled trial.

Effects of attenuated influenza virus administration to young children on pneumococcal density and acquisition in UK families: a randomised controlled trial.

Journal: The Lancet. Microbe
Published: November 20, 2024

Structure-activity studies of bispyridinium antinicotinics to select candidates to treat soman intoxication as part of a combined therapy.

Structure-activity studies of bispyridinium antinicotinics to select candidates to treat soman intoxication as part of a combined therapy.

Journal: PloS one
Published: November 07, 2024

The presenilin 1 mutation P436S causes familial Alzheimer's disease with elevated Aβ43 and atypical clinical manifestations.

The presenilin 1 mutation P436S causes familial Alzheimer's disease with elevated Aβ43 and atypical clinical manifestations.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: December 07, 2023

Efficacy of the oxime HI-6 dimethanesulphonate in the treatment of guinea-pigs exposed to the nerve agents GB and GD.

Efficacy of the oxime HI-6 dimethanesulphonate in the treatment of guinea-pigs exposed to the nerve agents GB and GD.

Journal: Toxicology letters
Published: September 27, 2023

CCN4 (WISP-1) reduces apoptosis and atherosclerotic plaque burden in an ApoE mouse model.

CCN4 (WISP-1) reduces apoptosis and atherosclerotic plaque burden in an ApoE mouse model.

Journal: Atherosclerosis
Published: August 24, 2023

First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer's disease: the Dominantly Inherited Alzheimer's Network Study.

First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer's disease: the Dominantly Inherited Alzheimer's Network Study.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: July 02, 2022

Nanoparticle-induced enhancement of cholinesterase activity in the presence of malathion: A potential nerve agent therapeutic.

Nanoparticle-induced enhancement of cholinesterase activity in the presence of malathion: A potential nerve agent therapeutic.

Journal: International journal of pharmaceutics
Published: June 21, 2022

Working correlates of protection predict SchuS4-derived-vaccine candidates with improved efficacy against an intracellular bacterium, Francisella tularensis.

Working correlates of protection predict SchuS4-derived-vaccine candidates with improved efficacy against an intracellular bacterium, Francisella tularensis.

Journal: NPJ vaccines
Published: July 27, 2021

Plasma amyloid-β ratios in autosomal dominant Alzheimer's disease: the influence of genotype.

Plasma amyloid-β ratios in autosomal dominant Alzheimer's disease: the influence of genotype.

Journal: Brain : a journal of neurology
Published: October 21, 2020
Showing 1-12 of 21

Last Updated: 09/26/2026